Cambridge Investment Research Advisors Inc. lessened its holdings in Merck & Co., Inc. (NYSE:MRK – Free Report) by 1.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 451,302 shares of the company’s stock after selling 7,497 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in […]